We'd go there, and it was just so fun
Large-scale trials demonstrate that semaglutide may modestly reduce systolic blood pressure by approximately 25 mmHg, likely due to weight loss and improved metabolic health
Medication Transfer to Breast Milk: What We Know and Don't Know Breast milk drug concentration depends on molecular properties, maternal metabolism, and lactation stage
[DOI] [PMC free article] [PubMed] [Google Scholar] 133.Bugajski AJ, et al
Patients on semaglutide, liraglutide, or tirzepatide should be told that excessive daytime sleepiness is a possible side effect, with an absolute incidence of roughly 0.40.7 percentage points above baseline at 1 to 5 years
Patients with a personal or family history of medullary thyroid carcinoma (MTC) or patients with multiple endocrine neoplasia syndrome type 2, the GLP-1 agonist are CONTRAINDICATED